G. Zhang et al. / Tetrahedron Letters 51 (2010) 987–989
989
N-(2-Bromo-2-(4-chlorophenyl)ethyl)-N,4-dimethylbenzenesulfonamide
isolated as
= 3448, 1596, 1491, 1048, 1158, 1089, 985, 828, 746, 715, 547 cmÀ1
NMR (300 MHz, CDCl3): d = 7.63 (d, J = 6.6 Hz, 2H), 7.39–7.30 (m, 6H), 5.12 (dd,
J = 6.6, 8.7 Hz, 1H), 3.67 (dd, J = 6.6, 14.4 Hz, 1H), 3.54 (dd, J = 8.7, 14.4 Hz, 1H),
2.60 (s, 3H), 2.43 (s, 3H) ppm. 13C NMR (75 MHz, CDCl3): d = 143.8, 137.5, 134.7,
134.5, 129.9, 129.5, 129.1, 127.3, 57.7, 50.6, 36.8, 21.6 ppm. MS (ESMS/
[M+Na]+): calcd for C16H17BrClNO2SNa: 425.97; found 426.17.
(2c)
yield without use of any catalyst. The introduction of N-methyl
group into nitrogen resource was found to be very important for
this aminohalogenation system, and can promote the formation
of haloamine product.
a
white solid (387 mg, 96% yield); mp 81–82 °C. IR (KBr):
m
.
1H
Acknowledgments
N-(2-Bromo-2-(4-bromophenyl)ethyl)-N,4-dimethylbenzenesulfonamide
isolated as white solid (425 mg, 95% yield); mp 108–110 °C. IR (KBr):
= 3461, 1596, 1489, 1346, 1158, 984, 821, 664, 551 cmÀ1 1H NMR (300 MHz,
CDCl3): d = 7.62 (d, J = 8.4 Hz, 2H), 7.48 (d, J = 6.6 Hz, 2H), 7.33–7.29 (m, 4H),
5.10 (dd, J = 6.6, 8.7 Hz, 1H), 3.66 (dd, J = 6.6, 14.7 Hz, 1H), 3.53 (dd, J = 8.7,
14.7 Hz, 1H), 2.60 (s, 3H), 2.43 (s, 3H) ppm. 13C NMR (75 MHz, CDCl3):
d = 143.9, 138.0, 134.4, 132.0, 129.9, 129.8, 127.4, 122.9, 57.6, 50.6, 36.8,
21.6 ppm. MS (ESMS/[M+Na]+): calcd for C16H17Br2NO2SNa: 469.92; found
470.00.
(2d)
a
We gratefully acknowledge the financial support from the Na-
tional Natural Science Foundation of China (No. 20772056, to
Y.P.). This work was also partially supported by research funds to
Y.P. from the Qing-Lan Program of Jiangsu Province and the Kua-
Shi-Ji Program of the Education Ministry of China. The Jiangsu
333 program (for Pan) was also acknowledged.
m
.
N-(2-Bromo-2-(4-nitrophenyl)ethyl)-N,4-dimethylbenzenesulfonamide
isolated as a yellow gum (384 mg, 93% yield); IR (KBr): = 3450, 1599, 1524,
1346, 1160, 857, 742, 670, 550 cmÀ1 1H NMR (300 MHz, CDCl3): d = 8.21 (d,
(2e)
m
References and notes
.
J = 9.0 Hz, 2H), 7.63 (d, J = 8.4 Hz, 4H), 7.32 (d, J = 8.4 Hz, 2H), 5.21 (t, J = 7.8 Hz,
1H), 3.64–3.62 (m, 2H), 2.62 (s, 3H), 2.43 (s, 3H) ppm. 13C NMR (75 MHz,
CDCl3): d = 148.0, 145.9, 144.1, 134.1, 130.0, 129.3, 127.4, 124.0, 57.5, 49.0,
36.9, 21.5 ppm. MS (ESMS/[M+Na]+): calcd for C16H17BrN2O4SNa: 437.00;
found 437.00.
1. (a) Kemp, J. E. G.. In Comprehensive Organic Synthesis; Trost, B. M., Fleming, I.,
Eds.; Pergamon: Oxford, 1991; Vol. 3, pp 471–513; (b) Griffith, D. A.;
Danishefsky, S. J. J. Am. Chem. Soc. 1991, 113, 5863; (c) Driguez, H.; Vermes, J.
P.; Lessard, J. Can. J. Chem. 1978, 56, 119; (d) Lessard, J.; Driguez, H.; Vermes, J.
P. Tetrahedron Lett. 1970, 11, 4887; (e) Daniher, F. A.; Butler, P. E. J. Org. Chem.
1968, 33, 4336; (f) Daniher, F. A.; Butler, P. E. J. Org. Chem. 1968, 33, 2637; (g)
Daniher, F. A.; Melchior, M. T.; Butler, P. E. Chem. Commun. 1968, 931; (h) Orlek,
B. S.; Stemp, G. Tetrahedron Lett. 1991, 32, 4045; (i) Qiu, J.; Silverman, R. B. J.
Med. Chem. 2000, 43, 706.
2. (a) Li, G.; Wei, H.; Kim, S. H.; Neighbors, M. Org. Lett. 1999, 1, 395; (b) Li, G.;
Wei, H.; Kim, S. H. Org. Lett. 2000, 2, 2249; (c) Wei, H.; Kim, S. H.; Li, G.
Tetrahedron 2001, 57, 3869; (d) Li, G.; Wei, H.; Kim, S. H. Tetrahedron 2001, 57,
8407; (e) Kotti, S. R. S. S.; Xu, X.; Wang, Y.; Headley, A. D.; Li, G. Tetrahedron Lett.
2004, 45, 7209; (f) Xu, X.; Kotti, S. R. S. S.; Liu, J.; Cannon, J. F.; Headley, A. D.; Li,
G. Org. Lett. 2004, 6, 4881; (g) Li, Q.; Shi, M.; Timmons, C.; Li, G. Org. Lett. 2006,
8, 625; (h) Liu, J.; Wang, Y.; Li, G. Eur. J. Org. Chem. 2006, 3112; (i) Han, J.; Zhi, S.;
Wang, L.; Pan, Y.; Li, G. Eur. J. Org. Chem. 2007, 1332; (j) Karur, S. S.; Kotti, S. R. S.
S.; Xu, X.; Cannon, J. F.; Headley, A. D.; Li, G. J. Am. Chem. Soc. 2003, 125, 13340.
3. (a) Bach, T.; Schlummer, B.; Harms, K. Chem. Commun. 2000, 287; (b) Minakata,
S.; Kano, D.; Oderaotoshi, Y.; Komatsu, M. Org. Lett. 2002, 4, 2097; (c) Nadir, U.
K.; Singh, A. Synth. Commun. 2004, 34, 1337; (d) Bach, T.; Schlummer, B.;
Harms, K. Chem. Eur. J. 2001, 7, 2581; (e) Yeung, Y.; Gao, X.; Corey, E. J. J. Am.
Chem. Soc. 2006, 128, 9644; (f) Rawal, G. K.; Kumar, A.; Tawar, U.; Vankar, Y. D.
Org. Lett. 2007, 9, 5171; (g) Manzoni, M. R.; Zabawa, T. P.; Kasi, D.; Chemler, S. R.
Organometallics 2004, 23, 5618; (h) Michael, F. E.; Sibbald, P. A.; Cochran, B. M.
Org. Lett. 2008, 10, 793.
4. (a) Chen, D.; Kim, S. H.; Hodges, B.; Li, G. ARKIVOC 2003, 56; (b) Huang, R.;
Shaughnessy, K. H. Organometallics 2006, 25, 4105; (c) Garrett, C. E.; Prasad, K.
Adv. Synth. Catal. 2004, 346, 889.
5. (a) Wang, Y.; Ni, B.; Headley, A. D.; Li, G. Adv. Synth. Catal. 2007, 349, 319; (b)
Wu, X.; Xia, J.; Wang, G. Org. Biomol. Chem. 2008, 6, 548; (c) Wu, X.; Wang, G. J.
Org. Chem. 2007, 72, 9398; (d) Minakata, S.; Yoneda, Y.; Oderaotoshi, Y.;
Komatsu, M. Org. Lett. 2006, 8, 967.
6. Huang, X.; Fu, W. Synthesis 2006, 1016.
7. (a) Chen, D.; Timmons, C.; Wei, H.; Li, G. J. Org. Chem. 2003, 68, 5742; (b)
Timmons, C.; Chen, D.; Xu, X.; Li, G. Eur. J. Org. Chem. 2003, 3850.
8. General aminobromination procedure (Table 2): A mixture of olefins (1.2 mmol),
p-TsNHMe (0.185 g, 1 mmol), and NBS (0.249 g, 1.4 mmol) was added in CH2Cl2
(3 mL) with stirring at 45 °C under nitrogen atmosphere for 24 h. The reaction
was quenched by dropwise addition of saturated aqueous Na2SO3 solution
(3 mL). The organic layer was separated and the aqueous layer was extracted
with EtOAc (3 Â 10 mL). The combined organic layers were washed with water
and brine and dried over by anhydrous Na2SO4 and concentrated under
reduced pressure to give crude product, which was purified by column
chromatography packed with silica gel to afford pure product.
N-(2-Bromo-2-(2-chlorophenyl)ethyl)-N,4-dimethylbenzenesulfonamide
isolated as white solid (391 mg, 97% yield); mp 74–76 °C. IR (KBr):
= 3445, 1596, 1335, 1156, 982, 751, 547 cmÀ1 1H NMR (300 MHz, CDCl3):
(2f)
a
m
.
d = 7.66–7.62 (m, 3H), 7.38–7.25 (m, 5H), 5.66 (dd, J = 7.2, 7.8 Hz, 1H), 3.83 (dd,
J = 7.8, 14.4 Hz, 1H), 3.53 (dd, J = 7.2, 14.4 Hz, 1H), 2.72 (s, 3H), 2.43 (s, 3H) ppm.
13C NMR (75 MHz, CDCl3): d = 143.8, 136.1, 134.4, 133.4, 130.0, 129.9, 129.9,
129.8, 127.6, 127.4, 56.2, 46.1, 36.0, 21.6 ppm. MS (ESMS/[M+Na]+): calcd for
C16H17BrClNO2SNa: 425.97; found 426.08.
N-(1-Bromo-2,3-dihydro-1H-inden-2-yl)-N,4-dimethylbenzenesulfonamide (2g)
isolated as
m
a
white solid (262 mg, 69% yield); mp 127–129 °C. IR (KBr):
= 3441, 1597, 1339, 975, 884, 810, 746, 693, 667, 549 cmÀ1
.
1H NMR
(300 MHz, CDCl3): d = 7.79 (d, J = 6.6 Hz, 2H), 7.38–7.16 (m, 6H), 5.11–5.10 (m,
2H), 3.36–3.28 (m, 1H), 2.85–2.78 (m, 1H), 2.56 (s, 3H), 2.48 (s, 3H) ppm. 13C
NMR (75 MHz, CDCl3): d = 143.7, 141.0, 140.3, 136.1, 129.9, 129.5, 127.9, 127.5,
125.4, 124.5, 66.6, 53.4, 33.8, 29.6, 21.7 ppm. MS (ESMS/[M+Na]+): calcd for
C17H18BrNO2SNa: 404.01; found 403.92.
N-(2-Bromocyclooctyl)-N,4-dimethylbenzenesulfonamide (2h) isolated as a white
solid (161 mg, 43% yield); mp 102–104 °C. IR (KBr):
m
= 3463, 2932, 2855, 1594,
1384, 1227, 1160, 985, 851, 801, 666, 645, 573, 547 cmÀ1
.
1H NMR (300 MHz,
CDCl3): d = 7.76 (d, J = 8.1 Hz, 2H), 7.28 (d, J = 8.1 Hz, 2H), 4.37–4.27 (m, 2H),
2.69 (s, 3H), 2.41 (s, 3H), 2.25–2.16 (m, 2H), 1.95 (m, 1H), 1.64–1.40 (m, 9H)
ppm. 13C NMR (75 MHz, CDCl3): d = 143.1, 137.1, 129.4, 127.6, 56.9, 31.3, 31.1,
28.1, 26.0, 25.0, 25.0, 23.5, 23.5, 21.5 ppm. MS (ESMS/[M+Na]+): calcd for
C16H24BrNO2SNa: 398.06; found 398.08.
N-(2-Bromoheptyl)-N,4-dimethylbenzenesulfonamide (2i) isolated as
solid (188 mg, 52 yield); mp 58–60 °C. IR (KBr): = 3417, 2953, 2857, 1638,
1618, 1384, 1342, 1162, 950, 907, 812, 752, 575, 552 cmÀ1 1H NMR (300 MHz,
a white
m
.
CDCl3): d = 7.68 (d, J = 8.4 Hz, 2H), 7.33 (d, J = 8.4 Hz, 2H), 4.14 (m, 1H), 3.46 (dd,
J = 7.5, 14.1 Hz, 1H), 3.18 (dd, J = 6.3, 14.1 Hz, 1H), 2.81 (s, 3H), 2.44 (s, 3H), 2.00
(m, 1H), 1.74–1.61 (m, 2H), 1.44–1.29 (m, 5H), 0.91 (t, 3H) ppm. 13C NMR
(75 MHz, CDCl3): d = 143.7, 134.3, 129.8, 127.4, 57.2, 53.6, 36.8, 35.6, 31.1, 27.0,
22.5, 21.5, 14.0 ppm. MS (ESMS/[M+Na]+): calcd for C15H24BrNO2SNa: 386.06;
found 386.17.
N-(2-(N,4-Dimethylphenylsulfonamido)-1-phenylethyl)acetamide (3a) isolated as
a white solid (256 mg, 74% yield); mp 132–134 °C. IR (KBr):
m
= 3334, 1650,
1595, 1539, 1444, 1369, 1340, 1166, 941, 771, 705, 659, 578, 552 cmÀ1
.
1H
NMR (300 MHz, CDCl3): d = 7.64 (d, J = 8.4 Hz, 2H), 7.32–7.29 (m, 7H), 6.70
(broad, 1H), 5.11 (m, 1H), 3.46 (dd, J = 6.6, 14.4 Hz, 1H), 3.01 (dd, J = 4.2,
14.4 Hz, 1H), 2.72 (s, 3H), 2.42 (s, 3H), 2.10 (s, 3H) ppm. 13C NMR (75 MHz,
CDCl3): d = 170.3, 143.8, 139.4, 134.6, 129.9, 128.8, 127.8, 127.2, 126.5, 54.9,
51.4, 35.8, 23.3, 21.5 ppm. MS (ESMS/[M+Na]+): calcd for C18H22N2O3SNa:
369.12; found 369.42.
N-(2-Bromo-2-phenylethyl)-N,4-dimethylbenzenesulfonamide (2a) isolated as a
white solid (346 mg, 94% yield); mp 61–63 °C. IR (KBr):
m
= 3418, 1618, 1491,
N-(2-Hydroxy-2-phenylethyl)-N,4-dimethylbenzenesulfonamide (4a) isolated as a
1384, 1334, 1159, 1088, 988, 934, 843, 812, 743, 705, 674, 644, 545 cmÀ1
.
1H
colorless gum (281 mg, 92% yield); IR (KBr):
m
= 3511, 3063, 3031, 2924, 1598,
1494, 1454, 1337, 1206, 1160, 1089, 972, 816, 760, 736, 701, 657, 550 cmÀ1
.
1H
NMR (300 MHz, CDCl3): d = 7.64 (d, J = 8.1 Hz, 2H), 7.29–7.45 (m, 7H), 5.15 (dd,
J = 7.2, 8.4 Hz, 1H), 3.73 (dd, J = 7.2, 14.4 Hz, 1H), 3.53 (dd, J = 8.4, 14.4 Hz, 1H),
2.59 (s, 3H), 2.43 (s, 3H) ppm. 13C NMR (75 MHz, CDCl3): d = 143.7, 139.0, 134.6,
129.9, 129.0, 128.9, 128.1, 127.4, 57.7, 51.9, 36.8, 21.6 ppm. MS (ESMS/
[M+Na]+): calcd for C16H18BrNO2SNa: 392.01; found 392.25.
NMR (300 MHz, CDCl3): d = 7.66 (d, J = 6.6 Hz, 2H), 7.39–7.29 (m, 6H), 4.92 (dd,
J = 3.3, 9.0 Hz, 1H), 3.28 (dd, J = 9.0, 14.1 Hz, 1H), 3.02 (dd, J = 3.3, 14.1 Hz, 1H),
2.80 (s, 3H), 2.41 (s, 3H) ppm. 13C NMR (75 MHz, CDCl3): d = 143.7, 141.2, 134.2,
129.8, 128.6, 128.0, 127.4, 126.1, 72.2, 58.3, 36.8, 21.5 ppm. MS (ESMS/
[M+Na]+): calcd for C16H19NO3SNa: 328.10; found 328.25.
N-(2-Bromo-2-(p-tolyl)ethyl)-N,4-dimethylbenzenesulfonamide (2b) isolated as a
white solid (370 mg, 97% yield); mp 92–94 °C. IR (KBr):
m = 3457, 1597, 1384,
9. (a) Wei, J.; Chen, Z.; Lei, W. Org. Lett. 2009, 11, 4216; (b) Wei, J.; Zhang, L.; Chen,
Z. Org. Biomol. Chem. 2009, 7, 3280; (c) Shaikh, T. M.; Karabal, P. U.;
Suryavanshi, G.; Sudalai, G. Tetrahedron Lett. 2009, 50, 2815; (d) Chen, Z.;
Wei, J.; Li, R. J. Org. Chem. 2009, 74, 1371; (e) Wang, Z.; Zhang, Y.; Fu, H. Synlett
2008, 2667; (f) Thakur, V. V.; Talluri, S. K.; Sudalai, A. Org. Lett. 2003, 5, 861.
10. Karabulut, H. R. F.; Kacan, M. Synth. Commun. 2002, 32, 2345.
1346, 1157, 1087, 985, 820, 733, 650, 571 cmÀ1 1H NMR (300 MHz, CDCl3):
.
d = 7.64 (d, J = 8.4 Hz, 2H), 7.32–7.30 (m, 4H), 7.16 (d, J = 7.8 Hz, 2H), 5.13 (dd,
J = 7.2, 8.4 Hz, 1H), 3.71 (dd, J = 7.2, 14.4 Hz, 1H), 3.54 (dd, J = 8.4, 14.4 Hz, 1H),
2.60 (s, 3H), 2.43 (s, 3H), 2.35 (s, 3H) ppm. 13C NMR (75 MHz, CDCl3): d = 143.7,
138.9, 136.1, 134.6, 129.8, 129.6, 127.9, 127.4, 57.6, 52.0, 36.8, 21.6, 21.3 ppm.
MS (ESMS/[M+Na]+): calcd for C17H20BrNO2SNa: 406.03; found 406.17.